MedTrace Logo

A Safety Study For Prevenar 13 Among Chinese Children

NCT03656939 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21240

Last updated 2021-08-27

Study results available
· View outcomes & findings →

Summary

This is an observational study based on a population-based EHR database.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
1 Month
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03656939 on ClinicalTrials.gov